Abstract
AbstractThree-dimensional (3D) cell cultures have emerged as valuable tools in cancer research, offering significant advantages over traditional two-dimensional (2D) cell culture systems. In 3D cell cultures, cancer cells are grown in an environment that more closely mimics the 3D architecture and complexity of in vivo tumors. This approach has revolutionized cancer research by providing a more accurate representation of the tumor microenvironment (TME) and enabling the study of tumor behavior and response to therapies in a more physiologically relevant context. One of the key benefits of 3D cell culture in cancer research is the ability to recapitulate the complex interactions between cancer cells and their surrounding stroma. Tumors consist not only of cancer cells but also various other cell types, including stromal cells, immune cells, and blood vessels. These models bridge traditional 2D cell cultures and animal models, offering a cost-effective, scalable, and ethical alternative for preclinical research. As the field advances, 3D cell cultures are poised to play a pivotal role in understanding cancer biology and accelerating the development of effective anticancer therapies. This review article highlights the key advantages of 3D cell cultures, progress in the most common scaffold-based culturing techniques, pertinent literature on their applications in cancer research, and the ongoing challenges.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference191 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
2. Grønning T. History of cancer. In: Colditz GA, editor. The sage encyclopedia of cancer and society. 2nd ed. CA: SAGE Publications, Inc.; 2015. p. 549–54.
3. Guimarães* I dos S, Daltoé* RD, Herlinger AL, Madeira KP, Ladislau T, Valadão IC, Junior PCML, Fernandes Teixeira S, Amorim GM, Santos DZ dos, Demuth KR, Rangel LBA. Conventional Cancer Treatment. Cancer Treatment—Conventional and Innovative Approaches. 2013; Available from: https://www.intechopen.com/chapters/42057.
4. De Vita VT. The evolution of therapeutic research in cancer. N Engl J Med. 2010;298(16):907–10.
5. Loessner D, Holzapfel BM, Clements JA. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses. Adv Drug Deliv Rev. 2014;15(79):193–213.